TalentLMS Offers TalentLMS Learning Software to Women-owned SMBs for International Women's Day
TalentLMS launches its Skills Accelerator Program to help female
entrepreneurs with upskilling and cultivating a culture of continuous learning.
SAN FRANCISCO, Feb. 19, 2025 /PRNewswire/ -- TalentLMS, a leading LMS for learning success, is proud to announce the launch of its Skills Accelerator Program for women-owned small and medium-sized businesses (SMBs). This initiative is designed to empower women entrepreneurs by providing them with the necessary technology and resources for employee reskilling and upskilling opportunities, helping foster a culture of continuous learning. TalentLMS will offer 20 selected women entrepreneurs full access to the industry-leading learning platform for one year.
In today's rapidly evolving business landscape, it is imperative to address the challenges faced by women-owned businesses. Economic and social imperatives underscore the importance of strengthening women entrepreneurs, not only as a matter of equality but also for economic growth and sustainability. Women-owned businesses often encounter obstacles such as limited access to capital and lower profitability compared to their male counterparts. According to a recent LinkedIn global study, organizations that invest in employee development report 15% higher productivity levels than those that don't.
TalentLMS recognizes these challenges and is committed to providing support to bridge the gender gap in entrepreneurship.
'At Epignosis, we believe that equal access to opportunities and resources is essential for building a more equitable and thriving business landscape. Women play a pivotal role in shaping the workforce and driving economic growth, yet too often face systemic barriers to success. With the launch of the TalentLMS Skills Accelerator Program for women-owned SMBs, we are taking deliberate action to break down these barriers and create pathways for women entrepreneurs to thrive,' said Nikhil Arora, CEO of Epignosis, parent company of TalentLMS. 'Investing in continuous learning isn't just beneficial—it's imperative. We are proud to support women-owned businesses that may lack the financial resources to invest in employee development, knowing that robust learning programs not only foster innovation and engagement but also drive long-term business success.'
The program will offer the selected women-owned SMBs access to TalentLMS, along with access to TalentLibrary™, a library of ready-made courses for training on soft skills and workplace topics. TalentLMS makes training easy, simple, and accessible. It ensures your learners are not only engaged but also grow and excel in their roles, significantly contributing to your company's success.
talentlms.com/iwd-skills-accelerator.
About TalentLMS
Trusted by 70,000 teams, TalentLMS is the training platform built for success and designed with simplicity in mind. With a course library, an intuitive interface, and all the tools you need to create transcendent training, you'll be up and running in no time.
SOURCE Epignosis
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Wheels Up Announces Divestiture of Non-Core Services Businesses
Continued streamlining of business operations to further company's profitability goals ATLANTA, Aug. 20, 2025 /PRNewswire/ -- Wheels Up Experience Inc. (NYSE: UP) today announced that it has sold three non-core services businesses – Baines Simmons, Kenyon International Emergency Services and Redline Assured Security – to an unrelated third party for approximately $20 million in proceeds before transaction-related expenses. Wheels Up expects to reinvest the net proceeds from the sale to further its ongoing fleet modernization strategy and for general corporate purposes. "The divestiture of these non-core services businesses is the latest in a series of steps that Wheels Up has taken to sharpen our strategic focus; invest in our product, fleet and operations; and strengthen our balance sheet," said George Mattson, Chief Executive Officer. "The sale, along with our recently announced initiatives estimated to drive approximately $50 million of cost efficiencies, is expected to create meaningful tailwinds on our path to sustained, profitable growth." The sale of these non-core services businesses complements continued efforts to streamline Wheels Up's business, drive operational performance and execute on the company's fleet simplification and modernization strategy. About Wheels UpWheels Up is a leading provider of on-demand private aviation in the U.S. with a large, diverse fleet and a global network of safety-vetted charter operators, all committed to safety and service. Customers access charter and membership programs and commercial travel benefits through a strategic partnership with Delta Air Lines. Wheels Up also provides cargo services to a range of clients, including individuals and government organizations. With the Wheels Up app and website, members can easily search, book, and fly. For more information, visit Cautionary Note Regarding Forward-Looking StatementsThis press release contains certain "forward-looking statements" within the meaning of the federal securities laws. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to known and unknown risks, uncertainties, assumptions, and other important factors, many of which are outside of the control of Wheels Up Experience Inc. ("Wheels Up"). These forward-looking statements include, but are not limited to, statements regarding the potential impacts of Wheels Up's cost reduction, operational efficiency and productivity initiatives and the divestiture of non-core businesses described in this press release on its business, financial condition and results of operations, including timing and magnitude. The words "anticipate," "continue," "could," "expect," "plan," "potential," "should," "would," "pursue" and similar expressions, may identify forward-looking statements, but the absence of these words does not mean that statement is not forward-looking. Factors that could cause actual results to differ materially from those expressed or implied in forward-looking statements can be found in Wheels Up's Annual Report on Form 10-K for the year ended December 31, 2024 filed with the U.S. Securities and Exchange Commission ("SEC") on March 11, 2025 and Wheels Up's other filings with the SEC from time to time. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Except as required by law, Wheels Up does not intend to update any of these forward-looking statements after the date of this press release. Investors:ir@ Media:press@ View original content to download multimedia: SOURCE Wheels Up
Yahoo
an hour ago
- Yahoo
REMAX NATIONAL HOUSING REPORT FOR JULY 2025
July's Home Sales Match 2024 Levels But Take Longer to Sell DENVER, Aug. 20, 2025 /PRNewswire/ -- After five consecutive months of gains, U.S. home sales dipped slightly in July, falling 0.7% below June's total. Compared to July 2024, sales were up 0.6%, but homes took longer to sell—averaging 44 days on the market, up from 37 days a year ago and three days longer than June, according to data from the 52 metro areas surveyed. The Median Sales Price in July was $450,000, down 1.1% from June – a typical seasonal trend. Year-over-year, prices were 2.3% higher. Inventory also saw a slight month-over-month decline of 0.8% but was 27.7% higher than July 2024. A 2.5% drop in new listings contributed to the monthly decrease, though new listings were still 4.4% above last year's levels. Shop Top Mortgage Rates A quicker path to financial freedom Personalized rates in minutes Your Path to Homeownership "July's housing data reflects a market that's adjusting seasonally," said REMAX CEO Erik Carlson. "Homes are taking a bit longer to sell, but inventory has remained consistent and prices have held steady. That's a sign of resilience—and continued opportunity for both buyers and sellers." In San Antonio, Texas, one of the top five markets in the report for housing supply, the 5.6-months' supply of inventory signals a more balanced environment. As the market continues to normalize, local expertise can be even more critical in helping clients navigate pricing and strategy. "While the number of sales was down and the days on market increased, the average sales price also continued to increase," said Sara Briseño Gerrish, Broker/Owner of RE/MAX Unlimited in San Antonio. "Now more than ever, it's crucial to work with an experienced real estate agent who understands the local market dynamics. This will ensure sellers have a comprehensive pricing strategy and buyers are able to leverage that expertise into a strong offer." Other metrics of note: Months' Supply of Inventory rose to 2.8 months, up slightly from 2.7 in June and higher than the 2.2 months recorded last July. Buyers paid an average of 99% of the asking price in July – the same as in June 2025 but below the 100% seen in July 2024. New listings grew year over year for a 17th consecutive month. Highlights and local market results for July include: New Listings In the 52 metro areas surveyed in July 2025, the number of newly listed homes was up 4.4% compared to July 2024, and down 2.5% compared to June 2025. The markets with the biggest increase in year-over-year new listings percentage were Houston, TX at +43.0%, Burlington, VT at +22.6%, and Raleigh, NC at +20.9%. The markets with the biggest year-over-year decrease in new listings percentage were Dover, DE at -34.6%, Baltimore, MD at -28.5%, and Philadelphia, PA at -28.0%. New Listings:5 Markets with the Biggest YoY Increase Market Jul 2025 Jul 2024 Year-over-Year % Change Houston, TX 17,556 12,276 +43.0 % Burlington, VT 326 266 +22.6 % Raleigh, NC 2,930 2,424 +20.9 % Wichita, KS 1,109 950 +16.7 % Omaha, NE 1,990 1,715 +16.0 % Closed Transactions Of the 52 metro areas surveyed in July 2025, the overall number of home sales was up 0.6% compared to July 2024, and down 0.7% compared to June 2025. The markets with the biggest increase in year-over-year sales percentages were Raleigh, NC at +19.5%, Bozeman, MT at +17.7%, and Manchester, NH at +12.4%. The markets with the biggest decrease in year-over-year sales percentage were Dover, DE at -10.9%, San Antonio, TX at -10.3%, and Miami, FL at -6.8%. Closed Transactions:5 Markets with the Biggest YoY Increase Market Jul 2025 Jul 2024 Year-over-Year % Change Raleigh, NC 2,263 1,893 +19.5 % Bozeman, MT 166 141 +17.7 % Manchester, NH 507 451 +12.4 % Houston, TX 8,157 7,488 +8.9 % Hartford, CT 1,261 1,183 +6.6 % Median Sales Price – Median of 52 metro area pricesIn July 2025, the median of all 52 metro area sales prices was $450,000, up 2.3% from July 2024, and down 1.1% compared to June 2025. The markets with the biggest year-over-year increase in median sales price were Bozeman, MT at +19.1%, Cleveland, OH at +13.0%, and Anchorage, AK at +10.3%. The markets with the biggest year-over-year decrease in median sales price were Burlington, VA at -5.0%, San Francisco, CA at -4.2%, and Houston, TX at -3.1%. Median Sales Price:5 Markets with the Biggest YoY Increase Market Jul 2025 Jul 2024 Year-over-Year% Change Bozeman, MT $789,500 $663,000 +19.1 % Cleveland, OH $274,700 $243,000 +13.0 % Anchorage, AK $445,000 $403,500 +10.3 % Trenton, NJ $531,500 $485,000 +9.6 % Indianapolis, IN $325,000 $304,000 +6.9 % Close-to-List Price Ratio – Average of 52 metro area pricesIn July 2025, the average close-to-list price ratio of all 52 metro areas in the report was 99%, down from 100% in July 2024 and the same as in June 2025. The close-to-list price ratio is calculated by the average value of the sales price divided by the list price for each transaction. When the number is above 100%, the home closed for more than the list price. If it's less than 100%, the home sold for less than the list price. The metro areas with the highest close-to-list price ratios were Hartford, CT at 104.4%, Trenton, NJ at 102.1%, and New York, NY at 102.0%. The metro areas with the lowest close-to-list price ratio were Miami, FL at 94.3%, New Orleans, LA at 96.3%, followed by a tie between Houston, TX and Tampa, FL at 96.7%. Close-to-List Price Ratio:5 Markets with the Highest Close-to-List Price Ratio Market Jul 2025 Jul 2024 Year-over-Year Difference* Hartford, CT 104.4 % 105.9 % -1.5 pp Trenton, NJ 102.1 % 103.1 % -1.0 pp New York, NY 102.0 % 101.5 % +0.5 pp San Francisco, CA 101.8 % 103.6 % -1.8 pp Milwaukee, WI 101.2 % 101.2 % +0.0 pp *Difference displayed as change in percentage points Days on Market – Average of 52 metro areasThe average days on market for homes sold in July 2025 was 44, up seven days compared to the average in July 2024 and up three days compared to June 2025. The metro areas with the highest days on market averages were San Antonio, TX at 83, Miami, FL at 78, and Phoenix, AZ at 75. The lowest days on market were Hartford, CT and Manchester, NH tied at 20, followed by Milwaukee, WI at 23. Days on market is the number of days between when a home is first listed in an MLS and a sales contract is signed. Days on Market:5 Markets with the Highest Days on Market Market Jul 2025 Jul 2024 Year-over-Year % Change San Antonio, TX 83 70 +18.2 % Miami, FL 78 59 +31.5 % Phoenix, AZ 75 59 +27.4 % Coeur d'Alene, ID 72 66 +9.0 % Tampa, FL 67 51 +31.0 % Months' Supply of Inventory – Average of 52 metro areasThe number of homes for sale in July 2025 was up 27.7% from July 2024, and down 0.8% from June 2025. Based on the rate of home sales in July 2025, the months' supply of inventory was 2.8, up from 2.2 from July 2024, and up from 2.7 from June 2025. In July 2025, the markets with the highest months' supply of inventory were Miami, FL at 7.1, Bozeman, MT at 5.8, and San Antonio, TX at 5.6. The markets with the lowest months' supply of inventory were Hartford CT at 1.0, followed by Manchester, NH and Milwaukee, WI tied at 1.1. Months' Supply of Inventory:5 Markets with the Highest Months' Supply of Inventory Market Jul 2025 Jul 2024 Year-over-Year % Change Miami, FL 7.1 5.0 +40.1 % Bozeman, MT 5.8 4.7 +21.8 % San Antonio, TX 5.6 5.1 +10.8 % Urban Honolulu, HI 5.1 2.3 +121.8 % Houston, TX 4.7 4.2 +12.5 % About the REMAX NetworkAs one of the leading global real estate franchisors, RE/MAX, LLC is a subsidiary of RE/MAX Holdings (NYSE: RMAX) with more than 145,000 agents in nearly 9,000 offices and a presence in more than 110 countries and territories. Nobody in the world sells more real estate than REMAX, as measured by residential transaction sides. REMAX was founded in 1973 by Dave and Gail Liniger, with an innovative, entrepreneurial culture affording its agents and franchisees the flexibility to operate their businesses with great independence. REMAX agents have lived, worked and served in their local communities for decades, raising millions of dollars every year for Children's Miracle Network Hospitals® and other charities. To learn more about REMAX, to search home listings or find an agent in your community, please visit For the latest news about REMAX, please visit Report DetailsThe REMAX National Housing Report is distributed monthly on or about the 15th. The Report is based on MLS data for the stated month in 52 metropolitan areas, includes single-family residential property types, and is not annualized. For maximum representation, most of the largest metro areas in the country are represented, and an attempt is made to include at least one metro area in almost every state. Metro areas are defined by the Core Based Statistical Areas (CBSAs) established by the U.S. Office of Management and Budget. DefinitionsClosed Transactions are the total number of closed residential transactions during the given month. Months Supply of Inventory is the total number of residential properties listed for sale at the end of the month (current inventory) divided by the number of sales contracts signed (pending listings) during the month. Where "pending" data is unavailable, an inferred pending status is calculated using closed transactions. Days on Market is the average number of days that pass from the time a property is listed until the property goes under contract. Median Sales Price for a metro area is the median sales price for closed transactions in that metro area. The nationwide Median Sales Price is calculated at the nationwide aggregate level using all sale prices from the included metro areas. The Close-to-List Price Ratio is the average value of the sales price divided by the list price for each closed transaction. MLS data is provided by Seventy3, LLC, a RE/MAX Holdings company. While MLS data is believed to be reliable, it cannot be guaranteed. MLS data is constantly being updated, making any analysis a snapshot at a particular time. Every month, the previous period's data is updated to ensure accuracy over time. Raw data remains the intellectual property of each local MLS organization. View original content to download multimedia: SOURCE RE/MAX, LLC
Yahoo
2 hours ago
- Yahoo
Onco360 adds Modeyso™ (dordaviprone) to portfolio of Oncology and Rare Cancer therapies as a National Specialty Pharmacy Provider
LOUISVILLE, Ky., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation's leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Jazz Pharmaceuticals for Modeyso™ (dordaviprone). It is indicated for the treatment of adult and pediatric patients one year of age and older with diffuse midline glioma harboring an H3 K27M-mutation with progressive disease following prior therapy.1 This indication was approved based on five open-label, non-randomized clinical trials conducted in the U.S. (ONC006 [NCT02525692], ONC013 [NCT03295396], ONC014 [NCT03416530], ONC016 [NCT05392374], and ONC018 [NCT03134131]).1 'Onco360 is grateful for the opportunity to add Modeyso™ to our expansive portfolio of cancer and rare disease therapies as the first and only FDA-approved treatment for pediatric and adult patients with diffuse midline glioma,' said Benito Fernandez. 'We are proud and humbled to be part of this innovative treatment in support of patients, caregivers and families impacted by this devastating disease.' Dordaviprone is a protease activator of the mitochondrial caseinolytic protease P (ClpP) and inhibits dopamine D2 receptor (DRD2). In vitro, dordaviprone activates the integrated stress response, induces apoptosis, and alters mitochondrial metabolism, leading to restored histone H3 K27 trimethylation in H3 K27M-mutant diffuse glioma.1 The efficacy of Modeyso was evaluated in an integrated efficacy population of 50 adult and pediatric patients with recurrent H3 K27M-mutant diffuse midline glioma enrolled across five open-label, non-randomized clinical trials.1 The primary outcome was overall response rate (ORR) of 22% (95% CI: 12,36). The trial also demonstrated a duration of response of 10.3 months (95% CI: 7.3, 15.2) with 73% maintaining their response for at least six months and 27% for at least 12 months.1 Dordaviprone demonstrated manageable safety and tolerability adverse events. The most common adverse reactions (≥20 %; all causality) experienced with dordaviprone were fatigue, headache, nausea, vomiting, and musculoskeletal pain.1 Please see the full Prescribing Information for Modeyso. About Onco360 Oncology Pharmacy:Onco360 is the nation's largest independent Oncology Pharmacy and clinical support services company. Onco360 was founded in 2003 to bring together the stakeholders involved in the cancer treatment process and serve the specialized needs of oncologists, patients, hospitals, cancer centers of excellence, manufacturers, health plans, and payers. It dispenses nationally through its network of URAC-, and ACHC-accredited Oncology Pharmacies. Onco360 is headquartered in Louisville, Kentucky, and is a flagship specialty pharmacy brand of PharMerica Corporation, a leading institutional pharmacy, specialty infusion, and hospital services company servicing healthcare facilities in the United States. For more information about Onco360, please visit Media Contact: Benito Fernandez, Chief Commercial References:1Modeyso™ (Dordaviprone) [Package Insert]. Palo Alto, CA. Jazz Pharmaceuticals. in to access your portfolio
